SLU-PP-332 5mg × 10
Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
SLU-PP-332 is a small molecule AMPK agonist that promotes lipolysis and energy expenditure by activating the fatty acid oxidation pathway, suitable for weight loss pharmaceutical raw materials or functional supplements.
Effects
Activates the AMPK signaling pathway to promote lipolysis; increases basal metabolism and energy expenditure; inhibits fat synthesis and storage; improves insulin sensitivity and metabolic health; aids in enhancing exercise endurance.
Usage
Subcutaneous injection: recommended starting dose of 5mg per administration, 1-2 times daily. The specific cycle should be adjusted based on individual metabolic response. It is recommended to use for 4-8 consecutive weeks followed by a 1-2 week break. Reconstitute with sterile diluent before use.
Suitable for
Overweight or obese individuals; those with metabolic syndrome or insulin resistance; individuals with specific fitness and weight loss needs; those with high body fat percentage who exercise regularly.
Not suitable for
Pregnant or breastfeeding women; individuals with severe heart disease, arrhythmia, or uncontrolled hypertension; those with hepatic or renal impairment; those allergic to any component of this product.
Ingredients
SLU-PP-332 (small molecule benzothiazolone compound, AMPK allosteric activator)
Storage
Store at 2-8°C, protected from light and moisture. Use within 24 hours after reconstitution.
Shelf life
24 months
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
